Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

ESMO Guidelines Committee

Research output: Contribution to journalArticlepeer-review

141 Scopus citations
Original languageEnglish
Pages (from-to)127-140
Number of pages14
JournalAnnals of Oncology
Volume34
Issue number2
DOIs
StatePublished - Feb 2023
Externally publishedYes

Bibliographical note

Funding Information:
AV and MD acknowledge the European Reference Network for Rare Solid Adult Cancers (EURACAN) for valuable input and networking. Manuscript editing support was provided by Richard Lutz and Claire Bramley ( ESMO Guidelines staff) and Angela Corstorphine and Sian-Marie Lucas of Kstorfin Medical Communications Ltd (KMC); this support was funded by ESMO . Nathan Cherny, Chair of the ESMO-MCBS Working Group, Urani Dafni, ESMO-MCBS Working Group Member/Frontier Science Foundation Hellas and Giota Zygoura of Frontier Science Foundation Hellas provided review and validation of the ESMO-MCBS scores. Nicola Latino ( ESMO Scientific Affairs staff) provided coordination and support of the ESMO-MCBS scores and Angela Corstorphine and Sian-Marie Lucas of KMC provided medical writing and editing support in the preparation of the ESMO-MCBS table; this support was funded by ESMO . Dr Benedikt Westphalen (member of the ESMO Translational Research and Precision Medicine Working Group) and Dr Svetlana Jezdic ( ESMO Medical Affairs Advisor) provided validation support for ESCAT scores.

Keywords

  • cholangiocarcinoma
  • diagnosis
  • follow-up
  • gallbladder cancer
  • precision medicine
  • treatment

Cite this